Thursday, 14 June 2018

Latest Updates : Heart Congress 2018 Postponed


On behalf of the Scientific Committee, We would like to inform you that Heart Congress 2018 which was originally scheduled on August 20-21, 2018 has been postponed to November 21-22, 2018 at Osaka, Japan.

The reason for the postpone was most of the Speaker  were not available during the month of August and they requested in change in dates so that it can enable their presence and help them in showcasing their latest research work with the world and rub elbows with the Leading Cardiologists from around the globe. So, our Scientific Committee has decided to postpone this event to enhance the participation and quality of this event.

We really regret for this inconvenience occurred. We hope you will understand and will show the same support towards Heart Congress 2018 which is about to take place in the Month of November at Osaka.

Note: Grab this opportunity to share your latest research work with the world.

For any other Queries (or) Chat with our Scientific Committee, Click Here

You can also get in touch with us @

Email ID 1 : heart[at]pulsusevents[dot]org

Email ID 2 : heartcongress[at]pulsusevents[dot]com

We look forward for you valuable support in making this conference a great success.

#HeartCongress2018    #EventPostponed   #November   @Osaka_Japan

Wednesday, 13 June 2018

Welcome on board New Organizing Committee Members | Heart Congress 2018

We are glad to have Dr. Ovidio A. Garcia-Villarreal (President of the Mexican College of Cardiovascular and Thoracic Surgery, Mexico ) & Dr. Anatoly Ryzhikh (President & CEO, Tyche MedTech, Inc., USA) on Board with us as one of our Organizing Committee Members for Heart Congress 2018....
Come and Meet Cardiology experts under a Single roof at Osaka this August..

For more Details, Please Visit our Official Webpage

For Tickets , Register Here

#HeartCongress2018    #Osaka_Japan   #ThisAugust   #AnCME-AccreditedEvent   
#OralPresentations    #Posters    #YRF    #RSC   #Arrhythmia_Alliance

Monday, 11 June 2018

The Connection Between Cardiovascular Disease and Sleep Apnea: An Expert Interview

A growing body of research has examined the relationship between sleep-disordered breathing and Cardiovascular Disease (CVD). Various findings have demonstrated that obstructive sleep apnea (OSA) is linked with a higher incidence of atrial fibrillation (AF), CVD, stroke, and heart failure, while central sleep apnea associated with Cheyne-Stokes respiration (CSA-CSR) is predictive of AF and heart failure.

A high prevalence of sleep apnea has been noted in cardiology patients, and researchers are increasingly focusing on OSA and CSA as potentially modifiable risk factors for CVD.
However, the clinical studies in this area thus far have produced mixed results. For example, a 2015 meta-analysis of randomized trials concluded that treatment of OSA with continuous positive airway pressure (CPAP) was associated with significant increases in body mass index (BMI) and weight, rather than the expected weight loss.

Numerous other trials have investigated the impact of CPAP on blood pressure, and the overall findings indicate a modest reduction, particularly in patients with resistant hypertension.3-5 In trials assessing the effects of OSA treatment on surrogate CV risk markers, including arterial stiffness, cardiac ejection fraction, and inflammatory markers, the “evidence is generally consistent with a positive effect of CPAP on vascular and metabolic functions and components of the atherosclerotic process,” according to a new white paper published in Circulation.1, 6-10,

In a large multicenter trial, patients assigned to OSA treatment with CPAP did not experience a significant decrease in hypertension or CV events, although further analysis revealed a significant reduction in the combined end points in adherent users (patients who used CPAP for ≥4 hours a night; incidence density ratio, 0.69; 95% CI, 0.50-0.94).11

Source: Cardiology Advisor

14 Days to expire!! Hurry Up | Heart Congress 2018

2nd Global Heart Congress 2018 123

Hurry Up!! Only 14 Days Left for this offer to expire... Don't miss this opportunity.. 

Get Registered for August 20-21, 2018 for only , this offer is valid until June 22nd, 2018 only....

To avail this offer email us at:       [Or]


Cardiology breakthroughs you need to know

For More Infromations regarding latest Breakthroughs, Please Click Here

#HeartCongres2018   #LatestAdvancements   #HeartHealth 

Saturday, 9 June 2018

Arrhythmia Associated With Higher Mortality in Congential Heart Disease-Related PAH

The presence of arrhythmia in patients with pulmonary arterial hypertension (PAH) and Congenital Heart Disease (CHD) is associated with worse long-term outcomes, according to a study published in Heart.

In this retrospective study, investigators evaluated outcomes data of patients with PAH-CHD who attended a tertiary center between January 2007 and December 2015 (n=310; mean age, 34.9±12.3 years). Investigators followed patients for new-onset atrial or ventricular arrhythmia, as well as supraventricular arrhythmias, during a median follow-up period of 6.1 years. A supraventricular arrhythmia included atrial fibrillation and supraventricular tachycardia

The presence of arrhythmia was identified using follow-up electrocardiograms (ECGs) as well as ECGs during hospital stay, ambulatory ECG recordings, implantable loop recordings, and/or device interrogation.

To read Full Article Click Here

Friday, 8 June 2018

Job strain could be harming your heart


Individuals with high-strain jobs are more likely to develop atrial fibrillation, which is a common heartbeat disorder that can significantly raise the risk of stroke.

For more details, Please Click Here